Trial Outcomes & Findings for Mindfulness-based Smoking Cessation Enhanced With Mobile Technology (NCT NCT04965181)

NCT ID: NCT04965181

Last Updated: 2025-12-30

Results Overview

Self-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by expired carbon monoxide \<6 ppm

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

504 participants

Primary outcome timeframe

8 weeks after the start of treatment

Results posted on

2025-12-30

Participant Flow

Participant milestones

Participant milestones
Measure
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
iQuit Mindfully
Participants will receive iQuit Mindfully text messages and nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Mindfulness-based Addiction Treatment (MBAT)
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Usual Care
Participants in the usual care condition are provided with nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Overall Study
STARTED
141
146
147
70
Overall Study
COMPLETED
122
134
126
61
Overall Study
NOT COMPLETED
19
12
21
9

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Mindfulness-based Smoking Cessation Enhanced With Mobile Technology

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=141 Participants
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
iQuit Mindfully
n=146 Participants
Participants will receive iQuit Mindfully text messages and nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Mindfulness-based Addiction Treatment (MBAT)
n=147 Participants
Participants will receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol and nicotine replacement therapy (NRT). MBAT consists of 8 weekly 2-hour sessions. NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Usual Care
n=70 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT). NRT consists of 8 weeks of generic nicotine patches and nicotine lozenges. Participants who smoke \>10 cigarettes/day will receive 4 weeks of 21 mg patches, 2 weeks of 14 mg patches, and 2 weeks of 7 mg patches. Those who smoke less than 10 cigarettes/day will receive 4 weeks of 14 mg patches and 4 weeks of 7 mg patches. Participants who smoke their first cigarette within 30 minutes of waking will receive 8 weeks of 4mg mini lozenges (6-9 4mg mini lozenges per day). Those who smoke their first cigarette over 30 minutes of waking will receive 8 weeks of 2mg mini lozenges (6-9 2mg mini lozenges per day). Participants will also be given the National Cancer Institute "Clearing the Air" booklet and a referral to the Tobacco Cessation Quitline.
Total
n=504 Participants
Total of all reporting groups
Age, Continuous
49.7 years
STANDARD_DEVIATION 12.8 • n=174 Participants
49.8 years
STANDARD_DEVIATION 12.3 • n=166 Participants
50.3 years
STANDARD_DEVIATION 13.1 • n=167 Participants
53.0 years
STANDARD_DEVIATION 12.7 • n=164 Participants
50.4 years
STANDARD_DEVIATION 12.7 • n=671 Participants
Sex: Female, Male
Female
57 Participants
n=174 Participants
54 Participants
n=166 Participants
56 Participants
n=167 Participants
32 Participants
n=164 Participants
199 Participants
n=671 Participants
Sex: Female, Male
Male
84 Participants
n=174 Participants
92 Participants
n=166 Participants
91 Participants
n=167 Participants
38 Participants
n=164 Participants
305 Participants
n=671 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=174 Participants
6 Participants
n=166 Participants
5 Participants
n=167 Participants
2 Participants
n=164 Participants
18 Participants
n=671 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
136 Participants
n=174 Participants
140 Participants
n=166 Participants
142 Participants
n=167 Participants
68 Participants
n=164 Participants
486 Participants
n=671 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=174 Participants
0 Participants
n=166 Participants
0 Participants
n=167 Participants
0 Participants
n=164 Participants
0 Participants
n=671 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=174 Participants
0 Participants
n=166 Participants
1 Participants
n=167 Participants
0 Participants
n=164 Participants
1 Participants
n=671 Participants
Race (NIH/OMB)
Asian
3 Participants
n=174 Participants
2 Participants
n=166 Participants
4 Participants
n=167 Participants
3 Participants
n=164 Participants
12 Participants
n=671 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=174 Participants
0 Participants
n=166 Participants
0 Participants
n=167 Participants
0 Participants
n=164 Participants
0 Participants
n=671 Participants
Race (NIH/OMB)
Black or African American
94 Participants
n=174 Participants
91 Participants
n=166 Participants
92 Participants
n=167 Participants
48 Participants
n=164 Participants
325 Participants
n=671 Participants
Race (NIH/OMB)
White
34 Participants
n=174 Participants
35 Participants
n=166 Participants
37 Participants
n=167 Participants
16 Participants
n=164 Participants
122 Participants
n=671 Participants
Race (NIH/OMB)
More than one race
6 Participants
n=174 Participants
13 Participants
n=166 Participants
6 Participants
n=167 Participants
1 Participants
n=164 Participants
26 Participants
n=671 Participants
Race (NIH/OMB)
Unknown or Not Reported
4 Participants
n=174 Participants
5 Participants
n=166 Participants
7 Participants
n=167 Participants
2 Participants
n=164 Participants
18 Participants
n=671 Participants
Cigarettes smoked per day at baseline
14.7 Number of cigarettes per day
STANDARD_DEVIATION 7.3 • n=174 Participants
15.4 Number of cigarettes per day
STANDARD_DEVIATION 9.8 • n=166 Participants
14.5 Number of cigarettes per day
STANDARD_DEVIATION 7.5 • n=167 Participants
13.6 Number of cigarettes per day
STANDARD_DEVIATION 7.6 • n=164 Participants
14.7 Number of cigarettes per day
STANDARD_DEVIATION 8.2 • n=671 Participants

PRIMARY outcome

Timeframe: 8 weeks after the start of treatment

Self-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by expired carbon monoxide \<6 ppm

Outcome measures

Outcome measures
Measure
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=93 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
iQuit Mindfully
n=108 Participants
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Mindfulness-based Addiction Treatment (MBAT)
n=101 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Usual Care
n=52 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
Number of Participants With Confirmed Smoking Abstinence, 8 Weeks
13 Participants
29 Participants
26 Participants
12 Participants

PRIMARY outcome

Timeframe: 12 weeks after the start of treatment

Self-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by expired carbon monoxide \<6 ppm

Outcome measures

Outcome measures
Measure
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=107 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
iQuit Mindfully
n=123 Participants
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Mindfulness-based Addiction Treatment (MBAT)
n=110 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Usual Care
n=55 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
Number of Participants With Confirmed Smoking Abstinence, 12 Weeks
17 Participants
27 Participants
22 Participants
9 Participants

PRIMARY outcome

Timeframe: 24 weeks after the start of treatment

Self-report of not smoking any combustible tobacco products in the past 7 days (not even a puff), confirmed by carbon monoxide \< 6ppm and saliva cotinine \< 20 ng/ml

Outcome measures

Outcome measures
Measure
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=107 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
iQuit Mindfully
n=124 Participants
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Mindfulness-based Addiction Treatment (MBAT)
n=120 Participants
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Usual Care
n=56 Participants
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
Number of Participants With Confirmed Smoking Abstinence, 24 Weeks
18 Participants
22 Participants
16 Participants
8 Participants

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported frequency of home mindfulness practice (questionnaire; higher frequency means better outcome)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; MAAS ranges 1-6)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported dispositional mindfulness (questionnaire; higher frequency means better outcome; FFMQ-SF ranges 24-120)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported self-compassion (questionnaire; higher frequency means better outcome; SCS-SF ranges 1-5)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported stress (questionnaire; lower scores mean better outcome; PSS ranges 0-40)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported positive and negative emotions (questionnaire; lower scores on PANAS-Negative Affect mean better outcome; higher scores on PANAS-Positive Affect mean better outcome; PANAS-Negative Affect and Positive Affect each range 10-50)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported craving and withdrawal (questionnaire; lower scores mean better outcome; subscale scores for each withdrawal symptom range 0-4)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported nicotine dependence (questionnaire; lower scores mean better outcome; subscale scores for each aspect of dependence range 1-7)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported self-efficacy to abstain from smoking (questionnaire; higher scores mean better outcome; subscale scores for managing positive affect, negative affect, and craving without smoking range 3-15)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: During 8 weeks of treatment; 8, 12 and 24 weeks after the start of treatment

Self-reported perceived social support (questionnaire)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 8 weeks after treatment

Feedback about interventions and perceived benefits (questionnaire; for quantitative questions, higher scores mean better outcome; for questions about helpfulness and recommending to others, scores range 1-10; for perceived benefits of program, scores range 1-5)

Outcome measures

Outcome data not reported

Adverse Events

Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully

Serious events: 0 serious events
Other events: 7 other events
Deaths: 0 deaths

iQuit Mindfully

Serious events: 1 serious events
Other events: 12 other events
Deaths: 0 deaths

Mindfulness-based Addiction Treatment (MBAT)

Serious events: 0 serious events
Other events: 12 other events
Deaths: 2 deaths

Usual Care

Serious events: 0 serious events
Other events: 8 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=141 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
iQuit Mindfully
n=146 participants at risk
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Mindfulness-based Addiction Treatment (MBAT)
n=147 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Usual Care
n=70 participants at risk
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
Psychiatric disorders
Severe disorientation (unrelated to study intervention)
0.00%
0/141 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
0.68%
1/146 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
0.00%
0/147 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
0.00%
0/70 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.

Other adverse events

Other adverse events
Measure
Mindfulness-based Addiction Treatment (MBAT) + iQuit Mindfully
n=141 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
iQuit Mindfully
n=146 participants at risk
Participants receive iQuit Mindfully text messages, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Mindfulness-based Addiction Treatment (MBAT)
n=147 participants at risk
Participants receive virtual group counseling based on the Mindfulness-Based Addiction Treatment (MBAT) group protocol, nicotine replacement therapy (NRT), and self-help materials in addition to regular check-in calls from the research team.
Usual Care
n=70 participants at risk
Participants in the usual care condition are provided with nicotine replacement therapy (NRT) and self-help materials, in addition to regular check-in calls from the research team.
Product Issues
Mild side effects of nicotine replacement therapy
5.0%
7/141 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
8.2%
12/146 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
8.2%
12/147 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.
11.4%
8/70 • 24 weeks
Adverse events were assessed via regular check-in calls with participants.

Additional Information

Claire Spears

Georgia State University

Phone: 404-413-9335

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place